Ebelinh pr.

Ebelinh PR. Clinical Practice. Osteoporosis in men. N Engl J Med. 2008 358 (14): 1474-82. Greenspan SL, Bone HG, Oettinger Deputy Hanley DA, Lindsay R, Zanchetta JR, et al. Effect of recombinant human parathyroid hormone glands (1-84) on vertebral fracture and bone mineral density in postmenopausal women suffering from osteoporosis: a randomized study. Ann internal Med. 2007 146 (5): 326-39. Greenspan SL, Nelson B., Trump lasix without prescription D. and Resnick NM. Influence of once a week oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized study. Ann internal Med. 2007 146 (6): 416-24. Heckbert SR, Li G, Cummings SR, Smith L., Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch internal Med. 2008 168 (8) :826-31. Kothawala P, Badamgarav E, S-ryu, Miller R. and Halbert RJ. A systematic review and meta-analysis of real commitment to drug treatment of osteoporosis. Mayo Clin Proc. 2007 82 (12): 1493-501. MacLean C, Newberry S, M Maglione, McMahon M, Ranganath V, Suttorp M., et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density and osteoporosis. Ann internal Med. 2008 148 (3): 197-213. National Endowment for osteoporosis. Clinical Guidelines for prevention and treatment of osteoporosis - 2008.

Washington, DC. Qasim, Snow V, Shekelle P, R Hopkins, Jr., Forciea A. Owens and DK. Pharmacological treatment of low bone density or osteoporosis to prevent fractures: clinical practice of the American College of Physicians. Ann internal Med. 2008 149 (6): 404-15. Tang BM, Eslick GD, Nowson C, C Smith, Bensussan A. Use of calcium or calcium in combination with vitamin D to prevent fractures and bone loss in people aged 50 years and older: results of meta-analysis. Lancet. 2007 August 25, 370 (9588) :657-66. .